U.S. Markets close in 10 mins

Ascendis Pharma A/S (ASND)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
95.40+4.27 (+4.69%)
As of 04:00PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.72
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3178.71
52 Week Low 361.58
50-Day Moving Average 3103.87
200-Day Moving Average 3129.26

Share Statistics

Avg Vol (3 month) 3603.23k
Avg Vol (10 day) 3929.89k
Shares Outstanding 556.93M
Implied Shares Outstanding 6N/A
Float 844.17M
% Held by Insiders 10.06%
% Held by Institutions 1106.18%
Shares Short (Apr 28, 2022) 45.76M
Short Ratio (Apr 28, 2022) 412.59
Short % of Float (Apr 28, 2022) 4N/A
Short % of Shares Outstanding (Apr 28, 2022) 410.12%
Shares Short (prior month Mar 30, 2022) 46.32M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-5,808.59%

Management Effectiveness

Return on Assets (ttm)-27.35%
Return on Equity (ttm)-44.54%

Income Statement

Revenue (ttm)7.78M
Revenue Per Share (ttm)0.14
Quarterly Revenue Growth (yoy)815.30%
Gross Profit (ttm)4.25M
EBITDA -447.81M
Net Income Avi to Common (ttm)-383.58M
Diluted EPS (ttm)-8.73
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)682.06M
Total Cash Per Share (mrq)12.01
Total Debt (mrq)104.96M
Total Debt/Equity (mrq)11.88
Current Ratio (mrq)8.03
Book Value Per Share (mrq)17.47

Cash Flow Statement

Operating Cash Flow (ttm)-417.65M
Levered Free Cash Flow (ttm)-281.9M